Case Study: Mercodia achieves new market growth with BearingPoint

Mercodia evaluates 3 new markets with BearingPoint

Mercodia, a world-leading developer of high-quality immunoassay kits for diabetes, obesity, and cardiovascular disease, sought to achieve growth by entering new markets. Their challenge was to evaluate expansion potential without compromising their renowned product and service quality, all while navigating extensive regulatory demands. They engaged BearingPoint to provide an evidence-based approach to identify existing needs in potential new markets.

BearingPoint assembled a cross-functional team of subject matter experts who leveraged the Ansoff matrix and conducted an evidence-driven analysis of new disease areas. They used workshops, a tailored selection criteria framework, and interviews with key opinion leaders to identify and evaluate three new markets. As a result of BearingPoint's engagement, Mercodia decided to pursue the market with the best strategic fit, obtaining sufficient information to support a move that would lead to market differentiation and potential growth.

Mercodia